About Terumo
About Terumo
About Terumo Top

Dear Stakeholders

Terumo Group Identity

Terumo Group Code of Conduct

Corporate Profile

Corporate Governance

Compliance

Regulations and Standards

Directors and Executive Officers

History

Procurement Activity
Back
Business Overview
Business Overview
Business Overview Top

TIS Division（Terumo Interventional Systems）

Neurovascular Division (MicroVention)

Cardiovascular Division (Terumo Cardiovascular) / HeartSheet Division

Cardiovascular Division (Terumo Cardiovascular)

HeartSheet Division

Vascular Graft Division (Terumo Aortic)

Hospital Systems Division

Alliance Division

Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
Back
Technology
Technology
Technology Top

Basic Information

Basic Information Top

Research and Development

Production and Supply

Intellectual Property

Terumo Fellows

Stories - Our Technologies
Back
Sustainability
Sustainability
Sustainability Top

News

Message from Top Management

Sustainability at the Terumo Group

Resolving Healthcare Challenges

Creating a Diverse and Inclusive Workplace

Reducing Environmental Footprint

Serving Our Communities

Report Library

Report Library Top

Back Numbers

GRI Standards Index
Back
Investors
Investors
Investors Top

Management Policy

Management Policy Top

Top Management Message

IR Policy

Business Risks

Financial Information

Shareholders & Stock

Shareholders & Stock Top

Stock Information

Shareholder Return

Chart

Credit Ratings and Corporate Bond

Analyst Coverage

Shareholders Meeting

Articles of Incorporation

IR Library

IR Library Top

Financial Statements

Presentations

Terumo Reports

Terumo Reports Top

Back Numbers

IR Events

Mail for IR Inquiry

Disclaimer
Back
Our Stories
Our Stories
Our Stories Top
Back
Newsroom
Newsroom
Newsroom Top

Newsroom2019

Newsroom2018

Newsroom2017

Newsroom2016

Newsroom2015

Newsroom2014
Back
Global Network
Global Network
Global Network Top

Japan

North America

South America

Europe, Middle East and Africa

Greater China

Asia and Pacific
Back

Newsroom 2021

October 21, 2021

Blood and Cell Technologies

Terumo Blood and Cell Technologies Opens Manufacturing Facility in Costa Rica
The company will offer 700 new jobs in diverse fields
October 7, 2021

Blood and Cell Technologies

Terumo Blood and Cell Technologies is collaborating with BioCentriq to provide technologies and expertise to automate cell and gene therapy manufacturing
October 4, 2021

Cardiac and Vascular

Terumo Aortic Announces First Implant of Landmark Thoracoabdominal Hybrid Device
September 21, 2021

Cardiac and Vascular

Terumo CVS Fully Exits Consent Decree
September 21, 2021

Cardiac and Vascular

Terumo Aortic Announces Launch of Landmark Global Surgical Graft Study
September 21, 2021

Corporate

Terumo India Releases Special Postal Cover and My Stamp to Commemorate 100 Years of Terumo Corporation
September 20, 2021

Corporate

Terumo Celebrates 100-Year Anniversary in Asia with an Eye to the Future
September 17, 2021

Corporate

Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare
September 17, 2021

Cardiac and Vascular

Terumo Aortic Announces First Commercial Implants of RelayPro Endovascular Device in the United States
September 14, 2021

Blood and Cell Technologies

Terumo Blood and Cell Technologies announces a new software update for its Finia® Fill and Finish System as the cell and gene therapy industry evolves toward automation
Finia was the first automation solution of its kind for the cell and gene market
September 9, 2021

Cardiac and Vascular

Etiometry and Terumo Cardiovascular Announce Partnership to Deliver Enhanced Monitoring Insights for Adult Cardiac Surgery Patients
New partnership will enable clinical decision support solutions to improve perioperative care for adult cardiac surgery patients
August 30, 2021

Cardiac and Vascular

MASTER DAPT, a Landmark Trial on Abbreviated DAPT Post-implantation of Terumo's Ultimaster™ DES in High Bleeding Risk Patients
Final results released @ ESC 2021 and simultaneously published in New England Journal of Medicine and Circulation
August 18, 2021

Blood and Cell Technologies

Health Canada Approves Mirasol Pathogen Reduction Technology System to Treat Platelets in Plasma
Mirasol Designed to Add a Layer of Safety to Blood Supply
August 11, 2021

Blood and Cell Technologies

Terumo Blood and Cell Technologies and PhotonPharma, Inc. Announce Collaboration to Develop a Novel Cancer Immunotherapy
1 in 3 people will be diagnosed with cancer in their lifetime, says American Cancer Society
August 6, 2021

Cardiac and Vascular

Terumo Aortic Announces US FDA Approval for RelayPro Endovascular Device
August 4, 2021

Financial

Terumo Revises its Full-Year Financial Guidance for FY2021
August 3, 2021

Financial

Notice of completion of disposal of treasury shares as Restricted Stock remuneration plan
August 3, 2021

Financial

Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants)
July 29, 2021

Blood and Cell Technologies

Global First-of-its-kind Study Published on the Positive Health Economic Impact of Overcoming Blood Shortages to Treat Maternal Bleeding in Sub-Saharan Africa
Peer-reviewed study in Africa Sanguine shows expanding investment in safe blood supply to prevent fatal post-partum hemorrhage (PPH) in Ghana, Kenya and Ivory Coast is likely to provide social benefits and substantial economic savings in under two years
July 27, 2021

General Hospital

Terumo Launches Dexcom G6 Continuous Glucose Monitoring (CGM) System in Japan
Support Diabetes Control with Real-Time Glucose Readings and a Predictive Alert for Low Glucose Levels
July 21, 2021

Blood and Cell Technologies

The Spectra Optia® Apheresis System from Terumo Blood and Cell Technologies in Combination with UVA PIT System Can Now be Used to Provide Extracorporeal Photopheresis Immunotherapy
The company is exploring new ways to help hospitals reach more patients with safe, reliable and cost-effective therapies
July 19, 2021

Cardiac and Vascular

Terumo and UMCU Strengthen their Partnership to Develop Solutions in Interventional Oncology
Terumo Europe and University Medical Center Utrecht signed a Memorandum of Understanding
July 14, 2021

Cardiac and Vascular

Terumo Introduces New AZUR™ Vascular Plug and PG Pro™ Peripheral Microcatheter Embolization System
Represents the next generation technology for peripheral vascular embolization
July 14, 2021

Financial

Notice regarding disposal of treasury shares as Restricted Stock remuneration
July 14, 2021

Financial

Notice Concerning the Issuance of Stock Options (Share Warrants)
June 29, 2021

Cardiac and Vascular

Roadsaver™ Carotid Stent System to Receive Reimbursement in France
The First Dual-layer Micromesh Carotid Stent to be Reimbursed
June 22, 2021

Corporate

Terumo Announces Voting Results for the Election of Directors
June 16, 2021

Corporate

Terumo Selected for the Global ESG Investment Index 'FTSE4Good Index Series' and 'FTSE Blossom Japan Index'
June 8, 2021

Blood and Cell Technologies

Terumo Blood and Cell Technologies Joins Cell and Gene Therapy Catapult Process Analytical Technology (PAT) Consortium
The company will contribute its full range of automation technology and scientific expertise to help accelerate technology development and potentially lower cost in cell and gene therapy manufacturing.
June 7, 2021

General Hospital

Innovative Therapies Combining Terumo Pharmaceutical Solutions
SurGuard3 safety hypodermic needles with disposable syringes to simplify administration and help prevent needlestick injury
May 14, 2021

Corporate

Terumo Donates Additional USD 1 Million to Support the COVID-19 Solidarity Response Fund for WHO
Contributions will Help Bolster Vaccine Equity
May 12, 2021

Financial

Terumo Announces Dividends for Fiscal Year Ended March 31, 2021 (increased payment)
May 12, 2021

Corporate

Terumo Appoints the Candidates for Directors
April 26, 2021

Blood and Cell Technologies

Terumo Blood and Cell Technologies announces participation in the Connecting the Dots video series, highlighting advanced medical therapies
April 21, 2021

Corporate

Terumo India Achieves 'Great Place to Work' Certification
April 19, 2021

Blood and Cell Technologies

Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform
Plasma is key ingredient for therapies crucial to treating patients affected by life-threatening conditions
April 12, 2021

Cardiac and Vascular

Terumo is Building a Global Therapeutic Interventional Oncology Team to Offer More Therapeutic Solution to Cancer Patients
March 18, 2021

General Hospital

Terumo and Glooko Announce Diabetes Technology Partnership to Deliver Integrated Diabetes Data Solution Globally
February 24, 2021

Corporate

Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc.
Transaction furthers Terumo’s efforts to improve patient outcomes and decrease healthcare costs through personalized predictive analytics and clinical decision support at the point of care
February 8, 2021

General Hospital

A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device Completes Clinical Study in Japan
Aiming to Reduce the Burden on Patients Receiving Ambulatory Chemotherapy
February 4, 2021

Corporate

Terumo to Establish 'DX Promotion Department' for Accelerating Group-wide Digital Transformation
February 4, 2021

Corporate

Terumo Announces Change of Directors and Executive Officers
February 4, 2021

Financial

Terumo Revises its Full-Year Financial Guidance for FY2020
January 26, 2021

Cardiac and Vascular

Terumo Aortic Announces Publication of the Primary Endpoint Results from the TREO Pivotal Study
January 26, 2021

Cardiac and Vascular

Terumo Aortic Announces Completion of Enrolment of the RelayPro US Transection Pivotal Study
January 12, 2021

Cardiac and Vascular

Lower-Profile WEB Intrasaccular Aneurysm Treatment Device Receives FDA Approval
January 7, 2021

Blood and Cell Technologies

Terumo Blood and Cell Technologies Grants $50,000 to Support Blood Donor Education Program
ADRP is developing resources to elevate awareness of the need for blood donations
January 5, 2021

Corporate

Terumo Enters 100th Anniversary Year

T
O
P